MAPT and Alzheimer disease: Imaging brain changes in Aβ with techniques such as computed tomography (CT), magnetic resonance index (MRI) and positron emission tomography (PET) in combination with the analysis of cerebrospinal fluid (CSF) have established Aβ and tau as an indicator of the AD disease.